-
Product Insights
Likelihood of Approval Analysis for Age Related Macular Degeneration
Overview How likely is it that the drugs in Age Related Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Age Related Macular Degeneration Overview Macular degeneration, also known as...
-
Product Insights
Likelihood of Approval Analysis for Macular Degeneration
Overview How likely is it that the drugs in Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Degeneration Overview Macular degeneration is primarily an age-related retinal condition. There...
-
Product Insights
Likelihood of Approval Analysis for Retinal Degeneration
Overview How likely is it that the drugs in Retinal Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Degeneration Overview Retinal degeneration refers to a group of diseases that...
-
Product Insights
Likelihood of Approval Analysis for Vision Disorders
Overview How likely is it that the drugs in Vision Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vision Disorders Overview Vision disorders are characterized by poor or unclear vision...
-
Product Insights
Likelihood of Approval Analysis for Wet (Neovascular / Exudative) Macular Degeneration
Overview How likely is it that the drugs in Wet (Neovascular / Exudative) Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Wet (Neovascular / Exudative) Macular Degeneration Overview Wet...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Nesvategrast in Non-Proliferative Diabetic Retinopathy (NPDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nesvategrast in Non-Proliferative Diabetic Retinopathy (NPDR) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nesvategrast in Non-Proliferative Diabetic Retinopathy (NPDR) Drug Details: Nesvategrast is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Nesvategrast in Proliferative Diabetic Retinopathy (PDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nesvategrast in Proliferative Diabetic Retinopathy (PDR) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nesvategrast in Proliferative Diabetic Retinopathy (PDR) Drug Details: Nesvategrast is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Umedaptanib Pegol in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Umedaptanib Pegol in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Umedaptanib Pegol in Wet (Neovascular / Exudative)...